Sinovac/CoronaVac Coronavirus inactivated Vaccine
From:Sinovac Biotech Ltd.(Sinovac Life Sciences)
Clinical Stage:Phase 3
Vaccine platform:Inactivated
Type of candidate vaccine: Inactivated
Number of doses:2
Timing of doses:0,14 days
Route of Administration: IM
Phase 3 report:
Phase 1/2 report:
NCT04383574
NCT04352608
StudyReport
NCT04551547